These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1649 related items for PubMed ID: 18191065

  • 21. [Insulin therapy].
    Brunetti P.
    Minerva Endocrinol; 2001 Jun; 26(2):65-86. PubMed ID: 11479436
    [Abstract] [Full Text] [Related]

  • 22. The importance of anti-insulin antibody in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion or multiple daily insulin injections therapy.
    Sahin SB, Cetinkalp S, Ozgen AG, Saygili F, Yilmaz C.
    Acta Diabetol; 2010 Dec; 47(4):325-30. PubMed ID: 20842389
    [Abstract] [Full Text] [Related]

  • 23. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
    Karges B, Muche R, Riegger I, Moritz M, Heinze E, Debatin KM, Wabitsch M, Karges W.
    Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
    [Abstract] [Full Text] [Related]

  • 24. Biphasic insulin aspart in the treatment of type 2 diabetes mellitus.
    Cucinotta D, Russo GT.
    Expert Opin Pharmacother; 2009 Dec; 10(17):2905-11. PubMed ID: 19929709
    [Abstract] [Full Text] [Related]

  • 25. Combining insulins for optimal blood glucose control in type I and 2 diabetes: focus on insulin glulisine.
    Ulrich H, Snyder B, Garg SK.
    Vasc Health Risk Manag; 2007 Dec; 3(3):245-54. PubMed ID: 17703632
    [Abstract] [Full Text] [Related]

  • 26. A single-center, randomized, double-blind, three-way crossover study examining postchallenge glucose responses to human insulin 70/30 and insulin lispro fixed mixtures 75/25 and 50/50 in patients with type 2 diabetes mellitus.
    Schwartz S, Zagar AJ, Althouse SK, Pinaire JA, Holcombe JH.
    Clin Ther; 2006 Oct; 28(10):1649-57. PubMed ID: 17157120
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Overnight CSII as supplement to oral antidiabetic drugs in type 2 diabetes.
    Parkner T, Møller MK, Chen JW, Laursen T, Jørgensen C, Smedegaard JS, Lauritzen T, Christiansen JS.
    Diabetes Obes Metab; 2008 Jul; 10(7):556-63. PubMed ID: 17593233
    [Abstract] [Full Text] [Related]

  • 30. Refining basal insulin therapy: what have we learned in the age of analogues?
    Devries JH, Nattrass M, Pieber TR.
    Diabetes Metab Res Rev; 2007 Sep; 23(6):441-54. PubMed ID: 17668418
    [Abstract] [Full Text] [Related]

  • 31. Pediatric quality of life in transitioning to the insulin pump: does prior regimen make a difference?
    Cogen FR, Henderson C, Hansen JA, Streisand R.
    Clin Pediatr (Phila); 2007 Nov; 46(9):777-9. PubMed ID: 17585009
    [Abstract] [Full Text] [Related]

  • 32. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I, Weiss R, Yegorchikov Y, Bitton G, Nagar R, Pesach B.
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [Abstract] [Full Text] [Related]

  • 33. [New methods in insulin treatment].
    Neuwirth G.
    Orv Hetil; 2005 Jan 16; 146(3):111-6. PubMed ID: 15693442
    [Abstract] [Full Text] [Related]

  • 34. Improved glycaemic control of thrice-daily biphasic insulin aspart compared with twice-daily biphasic human insulin; a randomized, open-label trial in patients with type 1 or type 2 diabetes.
    Clements MR, Tits J, Kinsley BT, Råstam J, Friberg HH, Ligthelm RJ.
    Diabetes Obes Metab; 2008 Mar 16; 10(3):229-37. PubMed ID: 18269638
    [Abstract] [Full Text] [Related]

  • 35. Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system.
    Mozdzan M, Ruxer J, Loba J, Siejka A, Markuszewski L.
    Adv Med Sci; 2006 Mar 16; 51():133-6. PubMed ID: 17357293
    [Abstract] [Full Text] [Related]

  • 36. Practical approaches to insulin therapy for type 2 diabetes mellitus with premixed insulin analogues.
    Rolla AR, Rakel RE.
    Clin Ther; 2005 Aug 16; 27(8):1113-25. PubMed ID: 16199240
    [Abstract] [Full Text] [Related]

  • 37. Continuous subcutaneous insulin infusion versus multiple daily injections in pregnant women with type 1 diabetes.
    González-Romero S, González-Molero I, Fernández-Abellán M, Domínguez-López ME, Ruiz-de-Adana S, Olveira G, Soriguer F.
    Diabetes Technol Ther; 2010 Apr 16; 12(4):263-9. PubMed ID: 20210564
    [Abstract] [Full Text] [Related]

  • 38. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
    Pickup JC, Sutton AJ.
    Diabet Med; 2008 Jul 16; 25(7):765-74. PubMed ID: 18644063
    [Abstract] [Full Text] [Related]

  • 39. The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences.
    Home PD.
    Diabetes Obes Metab; 2012 Sep 16; 14(9):780-8. PubMed ID: 22321739
    [Abstract] [Full Text] [Related]

  • 40. Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study.
    Bolli GB, Kerr D, Thomas R, Torlone E, Sola-Gazagnes A, Vitacolonna E, Selam JL, Home PD.
    Diabetes Care; 2009 Jul 16; 32(7):1170-6. PubMed ID: 19389820
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 83.